Financials

  • Market Capitalization 1.54 B
  • Employee 27
  • Founded 2015
  • CEO N/A
  • Website www.lbpharma.us
  • Headquarter Delaware, United States
  • FIGI BBG00XNP5MQ4
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-7.11
Fiyat/satışlar oranı
77.13

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2170
BCAX
Bicara Therapeutics Inc. - Common Stock
23.43 USD-5.64%-1.22%-10.20%+62.26%1.55 B USD
2171
XERS
Xeris Biopharma Holdings, Inc. - Common Stock
8.48 USD-1.40%-2.53%+1.19%+9.28%1.55 B USD
2179
NVAX
Novavax, Inc. - Common Stock
9.26 USD+2.32%+4.28%+24.63%+25.30%1.53 B USD
2184
INVA
Innoviva, Inc. - Common Stock
20.97 USD+0.05%-0.47%-1.78%+17.68%1.51 B USD